Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Oncor, Inc. (OTC BB:ONCR.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: nothing available.
Location
209 Perry Parkway
Gaithersburg, MD 20877
Phone: (301) 963-3500
Fax: (301) 926-6129
Employees (last reported count): 3
Financial Links
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 27%
·Institutional: 1% (1% of float)
(2 institutions)
·Net Inst. Selling: 6,000  shares (+3.08%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Oncor Inc. sold its 80% interest in Appligene Oncore, a French company, to a Canadian company for $1 million in February 1999. After the sale of Appligene, the Company's only remaining assets consisted of certain Oncor and Codon intellectual property and licenses. The future uses, if the Company is exploring any, of these remaining assets. In February 1999, Oncor, Inc. and its wholly-owned subsidiary, Codon Pharmaceuticals, Inc., filed voluntary petitions for relief under Chapter 11 of the United States Code with the United States Bankruptcy Court for the District of Delaware, Wilmington, Delaware. Oncor expects to reorganize under Chapter 11 and to propose a reorganization plan or plans.
More from Market Guide: Expanded Business Description

Financial Summary
Oncor develops, produces and markets cancer-oriented genetic probes, related reagents, molecular biology products and diagnostic products for the detection and management of certain cancers. For the six months ended 6/30/99, revenues fell 90% to $720 thousand. Net loss applicable to Common fell 93% to $1.1 million. Revenues reflect the company's disposition of Appilgene. Lower loss reflect lowered direct costs and expenses due to the reduced scope of operations.
More from Market Guide: Significant Developments

Officers
FY1998 Pay

Jose Coronas, 54
Chairman and Acting Sec.
$133K
Dollar amounts are as of 31-Dec-1998 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ONCR.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 24-Nov-2000
$0.001
Recent Price$0.002
52-Week High
on 16-Feb-2001
$0.05 
Beta-3.96 
Daily Volume (3-month avg)3,000 
Daily Volume (10-day avg)2,000 
Stock Performance
52-Week Change-86.7%
52-Week Change
relative to S&P500
-82.1%
Share-Related Items
Market Capitalization$67.0K
Shares Outstanding33.6M
Float24.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.38 
Earnings (ttm)-$0.53 
Earnings (mrq)-$0.01 
Sales (ttm)$0.17 
Cash (mrq)$0.06 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)0.01 
Income Statements
Sales (ttm)$5.42M
EBITDA (ttm)-$10.0M
Income available to common (ttm)-$16.8M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-1999
Management Effectiveness
Return on Assets (ttm)-128.41%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)5.83 
Debt/EquityN/A 
Total Cash (mrq)$1.97M
Short Interest
As of 9-Nov-1998
Shares Short1.72M
Percent of Float7.0%
Shares Short
(Prior Month)
1.72M
Daily Volume0 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-1999)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.